Table of Contents
Chemotherapy Research and Practice
Volume 2011, Article ID 602812, 6 pages
http://dx.doi.org/10.1155/2011/602812
Clinical Study

Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma

1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
2Advanced Medicine Center, 875 Blake Wilbur Drive, CC2221 Stanford, CA 94305, USA
3Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA

Received 18 April 2011; Revised 12 June 2011; Accepted 8 July 2011

Academic Editor: Evangelia D. Razis

Copyright © 2011 Seema Nagpal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Jia Wan, Edina Csaszar, Wei-Qiang Chen, Kongzhao Li, and Gert Lubec, “Proteins from Avastin (R) (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear,” Plos One, vol. 7, no. 4, 2012. View at PublisherView at Google Scholar
  • Vladimir P. Chekhonin, Anna A. Korchagina, Sergey A. Shein, and Olga I. Gurina, “VEGF in Tumor Progression and Targeted Therapy,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 423–443, 2013. View at PublisherView at Google Scholar
  • Andrew D. Norden, Eudocia Q. Lee, Rameen Beroukhim, Lakshmi Nayak, Patrick Y. Wen, and Mikael L. Rinne, “Update on bevacizumab and other angiogenesis inhibitors for brain cancer,” Expert Opinion On Emerging Drugs, vol. 18, no. 2, pp. 137–153, 2013. View at PublisherView at Google Scholar
  • David E. Piccioni, Julia Selfridge, Reema R. Mody, Reshmi Chowdhury, Sichen Li, Shadi Lalezari, James Wawrzynski, Jennifer Quan, Mira Zurayk, Arthur P. Chou, Desiree E. Sanchez, Linda M. Liau, Benjamin M. Ellingson, Whitney B. Pope, Phioanh L. Nghiemphu, Richard M. Green, He-jing Wang, William H. Yong, Robert Elashoff, Timothy F. Cloughesy, and Albert Lai, “Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy,” Neuro-Oncology, vol. 16, no. 6, pp. 815–822, 2014. View at PublisherView at Google Scholar
  • Jeremy Rees, “Updates in the management of high-grade glioma,” Journal of Neurology, vol. 261, no. 4, pp. 651–654, 2014. View at PublisherView at Google Scholar
  • Bruce Ovbiagele, Seema Nagpal, Scott G Soltys, Gordon Li, Griffith Harsh, and Lawrence RechtBest Practices in Neurological Care, pp. 110–125, 2014. View at PublisherView at Google Scholar
  • Yoshitaka Narita, “Bevacizumab for glioblastoma,” Therapeutics And Clinical Risk Management, vol. 11, pp. 1759–1765, 2015. View at PublisherView at Google Scholar
  • Oliver Schnell, Jun Thorsteinsdottir, Daniel Felix Fleischmann, Markus Lenski, Wolfgang Abenhardt, Armin Giese, Jörg-Christian Tonn, Claus Belka, Friedrich Wilhelm Kreth, and Maximilian Niyazi, “Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma,” Journal of Neuro-Oncology, 2016. View at PublisherView at Google Scholar
  • Philip J. O’Halloran, Thomas Viel, David W. Murray, Lydia Wachsmuth, Katrin Schwegmann, Stefan Wagner, Klaus Kopka, Monika A. Jarzabek, Patrick Dicker, Sven Hermann, Cornelius Faber, Tim Klasen, Michael Schäfers, David O’Brien, Jochen H. M. Prehn, Andreas H. Jacobs, and Annette T. Byrne, “Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. 9, pp. 1673–1683, 2016. View at PublisherView at Google Scholar
  • Danielle N. Renner, Courtney S. Malo, Fang Jin, Ian F. Parney, Kevin D. Pavelko, and Aaron J. Johnson, “Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model,” Neurotherapeutics, vol. 13, no. 1, pp. 226–236, 2016. View at PublisherView at Google Scholar
  • Roberto Jose Diaz, Sheikh Ali, Mehreen Gull Qadir, Macarena I. De La Fuente, Michael E. Ivan, and Ricardo J. Komotar, “The role of bevacizumab in the treatment of glioblastoma,” Journal of Neuro-Oncology, 2017. View at PublisherView at Google Scholar